Zacks Research upgraded shares of Carl Zeiss Meditec (OTCMKTS:CZMWY – Free Report) from a strong sell rating to a hold rating in a research report sent to investors on Tuesday morning,Zacks reports.
Other research analysts also recently issued research reports about the company. UBS Group downgraded Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. Morgan Stanley assumed coverage on shares of Carl Zeiss Meditec in a research report on Wednesday, September 2nd. They set an “underweight” rating on the stock. Finally, The Goldman Sachs Group lowered Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a research report on Monday. Two investment analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Carl Zeiss Meditec has an average rating of “Strong Sell”.
Read Our Latest Analysis on Carl Zeiss Meditec
Carl Zeiss Meditec Stock Performance
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG is a Germany-based medical technology company focused on ophthalmology and microsurgery. The company develops, manufactures and distributes diagnostic and therapeutic systems, surgical equipment, implants and related digital solutions for healthcare professionals.
Its ophthalmic portfolio includes devices for eye examinations and diagnostics, laser systems for refractive and cataract procedures, surgical microscopes, intraocular lenses and other products used in cataract, retinal, glaucoma and corneal treatments.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
